Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	11,287	10,418	16,680	17,832	-	-
Market Cap Growth	4.58%	-37.54%	-6.46%	-	-	-
Enterprise Value	8,212	8,180	14,346	15,905	-	-
Last Close Price	18.97	16.80	25.82	27.44	-	-
PE Ratio	160.19	50.69	19.40	34.32	-	-
Forward PE	10.48	9.86	15.22	-	-	-
PS Ratio	11.56	9.24	6.92	9.77	-	-
PB Ratio	1.99	1.73	2.66	3.24	-	-
P/TBV Ratio	2.00	1.74	2.67	3.26	-	-
P/FCF Ratio	40.02	25.02	20.21	90.98	-	-
P/OCF Ratio	37.70	22.26	18.78	61.78	-	-
EV/Sales Ratio	8.41	7.25	5.95	8.71	-	-
EV/EBITDA Ratio	134.86	34.81	14.03	24.91	-	-
EV/EBIT Ratio	-	86.43	16.27	31.55	-	-
EV/FCF Ratio	29.11	19.64	17.38	81.14	-	-
Debt / Equity Ratio	-	0.05	0.05	0.06	0.18	0.09
Debt / EBITDA Ratio	-	1.28	0.29	0.47	0.68	0.18
Debt / FCF Ratio	-	0.72	0.36	1.53	-	1.24
Asset Turnover	0.13	0.14	0.32	0.32	0.45	0.89
Inventory Turnover	1.13	1.50	2.24	2.69	4.64	5.71
Quick Ratio	3.02	3.19	2.73	2.57	1.43	1.65
Current Ratio	3.26	3.40	3.10	2.73	1.51	1.70
Return on Equity (ROE)	1.20%	3.35%	14.63%	12.51%	24.86%	53.63%
Return on Assets (ROA)	-0.67%	0.76%	7.32%	5.43%	10.28%	24.23%
Return on Invested Capital (ROIC)	-2.92%	2.58%	19.83%	14.81%	30.53%	73.15%
Return on Capital Employed (ROCE)	-1.40%	1.60%	14.00%	9.10%	23.60%	48.10%
Earnings Yield	0.62%	1.97%	5.16%	2.91%	-	-
FCF Yield	2.50%	4.00%	4.95%	1.10%	-	-
Dividend Yield	3.18%	1.19%	2.32%	0.73%	-	-
Payout Ratio	196.37%	162.67%	13.95%	17.49%	2.06%	0.50%
Buyback Yield / Dilution	1.11%	0.71%	-2.03%	-9.33%	-0.01%	0.24%
Total Shareholder Return	4.31%	1.91%	0.29%	-8.61%	-0.01%	0.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.